Collective Family Office LLC Regeneron Pharmaceuticals, Inc. Transaction History

Collective Family Office LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$775.18 - $881.7 $76,742 - $87,288	-99 Reduced 27.89%	256 $224,000
Q3 2023 Oct 13, 2023	BUY	$692.45 - $844.37 $34,622 - $42,218	50 Added 16.39%	355 $292,000
Q2 2023 Jul 12, 2023	BUY	$700.03 - $830.35 $213,509 - $253,256	305 New	305 $219,000
Q2 2022 Jul 18, 2022	BUY	$548.35 - $738.84 $94,316 - $127,080	172 Added 56.58%	476 $281,000
Q1 2022 Apr 25, 2022	SELL	$595.12 - $698.43 $92,243 - $108,256	-155 Reduced 33.77%	304 $212,000
Q4 2021 Jan 18, 2022	SELL	$543.48 - $670.97 $10,326 - $12,748	-19 Reduced 3.97%	459 $290,000
Q3 2021 Oct 08, 2021	SELL	$574.03 - $680.96 $1,722 - $2,042	-3 Reduced 0.62%	478 $289,000
Q2 2021 Jul 14, 2021	SELL	$472.8 - $558.54 $35,460 - $41,890	-75 Reduced 13.49%	481 $269,000
Q1 2021 Apr 14, 2021	BUY	$446.73 - $548.2 $248,381 - $304,799	556 New	556 $263,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Collective Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Collective Family Office LLC with notifications on news.